Peter H J Slootbeek

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Ejection Fraction

Top Venues

British journal of cancer

Critical reviews in clinical laboratory sciences

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Peter H J Slootbeek, Sofie H Tolmeijer, Niven Mehra, Jack A Schalken
Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter? Critical reviews in clinical laboratory sciences (2023)
Peter H J Slootbeek, Iris S H Kloots, Inge M van Oort, Leonie I Kroeze, Jack A Schalken, Haiko J Bloemendal, Niven Mehra
Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer. Cancers 15 (10) (2023)
Peter H J Slootbeek, Iris S H Kloots, Minke Smits, Inge M van Oort, Winald R Gerritsen, Jack A Schalken, Marjolijn J L Ligtenberg, Katrien Grünberg, Leonie I Kroeze, Haiko J Bloemendal, Niven Mehra
Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer. British journal of cancer 126 (6) (2021)
Peter H J Slootbeek, Marleen L Duizer, Maarten J van der Doelen, Iris S H Kloots, Malou C P Kuppen, Hans M Westgeest, Carin A Uyl-de Groot, Samhita Pamidimarri Naga, Marjolijn J L Ligtenberg, Inge M van Oort, Winald R Gerritsen, Jack A Schalken, Leonie I Kroeze, Haiko J Bloemendal, Niven Mehra
Impact of DNA damage repair defects and aggressive variant features on response to carboplatin-based chemotherapy in metastatic castration-resistant prostate cancer. International journal of cancer 148 (2) (2020)